Combined rapid test for Covid-19 and influenza
Corona numbers are rising, and the next challenge is already in sight: Flu season is beginning. The symptoms can be very similar, but a test can differentiate between influenza and Covid-19.A new combined rapid test can detect coronavirus and influenza viruses simultaneously: The NADAL® COVID-19 Ag+Influenza A/B Test from German medical technology company nal von minden delivers a reliable result in just 15 minutes.
Symptoms like fever, cough, sore throat and fatigue can occur with both influenza and Covid-19 infections. Suspected coronavirus cases could therefore actually be influenza cases – or vice versa.
"Differentiating between coronavirus and influenza is enormously important in order to avoid further spread of the coronavirus and to protect ourselves and others faster and better", says Thomas Zander, managing director of nal von minden GmbH, based in Moers, Germany. "The new combined rapid test for Covid-19 and influenza can help contain the spread of the virus."
The NADAL® COVID-19 antigen/influenza combined test can be carried out on site. A laboratory is not necessary. For the test, a swab from the oral cavity or nasopharynx is collected by medical personnel. The result is available within 15 minutes. Zander: "It is much more pleasant for affected individuals to have just one sample collected, rather than two, to check for two possible infections." The new combined test also takes the pressure off laboratories, which cannot process unlimited numbers of time-consuming tests.
Possible areas of application for the new combined test are primarily nursing and care homes, as older people are particularly at risk. The combined test is also useful in hospitals, for example in case of rapid emergency admission of patients. It could also be used within companies to test employees with unclear cold symptoms. "However, within a company, the test must be carried out by a doctor", adds Zander.
nal von minden GmbH has already produced millions of combined antigen tests, which are available immediately. The test is already approved throughout Europe.
- Picture is available at AP Images (http://www.apimages.com) -
+49 40 38 66 24 80
Följ nal von minden GmbH
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från nal von minden GmbH
Did my vaccine work? New rapid test for the determination of vaccination success.25.5.2021 11:25:37 CEST | Press release
Am I really protected against the coronavirus now? This is a question asked by many after receiving a vaccination. The medtech company nal von minden from Moers in Germany has now developed a rapid test that can reliably detect antibodies against COVID-19 pathogens in blood. The NADAL® COVID-19 S1-NAb Test is now available all over Europe.
COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease.7.1.2021 12:10:24 CET | Pressmeddelande
Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes.
Corona rapid test: Celebrate Christmas together without anyone getting infected15.12.2020 13:57:54 CET | Press release
In many places, uncertainty is now mixed in with the anticipation of Christmas: will Christmas be a “super spreader event” as many politicians are warning? “No”, Roland Meissner, the CEO of nal von minden in Moers, Germany is convinced: “you can protect your relatives as best as possible by getting tested for corona beforehand.” There are also tips to minimize the risk of corona during the actual festivities.
nal von minden plans to produce 80 million rapid corona tests per month20.11.2020 11:43:34 CET | Pressmeddelande
Rapid corona testing is playing an increasingly important role in containing the pandemic everywhere – even though the first vaccines are now in sight. The medical technology company nal von minden GmbH from Moers, Germany, is therefore doubling its production: 40 million rapid antigen tests are already being produced in November. By January, this figure is expected to rise to 80 million – every month!
New Covid-19 antigen test: Fast and reliable results in just 15 minutes23.10.2020 16:14:31 CEST | Pressmeddelande
Preventing further spread of the coronavirus and taking pressure off laboratories – it is possible with the NADAL® Covid-19 Antigen Test from Germany. Whether in schools, nursing homes, hospitals, companies, or at the airport or larger events: The result is available in just 15 minutes. The new rapid test from medical technology company nal von minden GmbH is already approved in Europe and is available immediately. The high quality has been repeatedly verified.
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum